Dr Adam Devall BMedSc (Hons), PhD

Dr Adam Devall

Department of Metabolism and Systems Science
Professor of Maternal Health Clinical Trials
Tommy's National Centre for Miscarriage Research and WHO Collaborating Centre for Global Women’s Health

Contact details

Address
University of Birmingham
Edgbaston
Birmingham
B15 2TT
UK

Adam's primary research focus is clinical trials in early pregnancy care, with a particular focus on miscarriage, infertility and global women’s health. As Professor of Maternal Health Clinical Trials, he collaborates with the Birmingham Clinical Trials Unit to manage a portfolio of national and international clinical trials. He is also a senior consortium member of the Tommy's National Centre for Miscarriage Research, led by Professor Arri Coomarasamy.

Qualifications

  • PhD in Neuropharmacology, University of Birmingham, 2007
  • BMedSc (Hons) Pharmacology, University of Birmingham, 2003

Biography

Adam Devall qualified with a BMedSc (Hons) in Medical Sciences from the University of Birmingham in 2003. He went on to study for a PhD in the Department of Pharmacology at Birmingham, which he was awarded in 2007. Following this, he took a position as a Research Fellow at the University of Birmingham in the Department of Neurobiology and Neuropharmacology before taking up the role of Trial Coordinator at the Cancer Research Clinical Trials Unit, University of Birmingham in 2011. In 2014, Adam moved to the Birmingham Clinical Trials Unit, working initially as a Senior Trial Manager for the PRISM trial. In 2016, Adam transitioned to the role of Trials Management Team Leader/Senior Clinical Trials Fellow, before moving to his current academic lecturer post in January 2021. 

Teaching

Adam teaches on the Clinical Trials MSc course.

Research

Adam Devall has a wide range of large research programs within his portfolio, which are listed below:

Principal Investigator 

Progestogens for preventing miscarriage: a network meta-analysis. £10,000. NIHR Incentive Awards Scheme. 2020-2022

Co-applicant

  • Tommy’s National Centre for Miscarriage Research. £2,500,000 plus institutional investment. Tommy’s. 2021-2026.
  • Development, Field-Testing and Piloting of a refractory postpartum haemorrhage management package: the PPH ReAct (PPH Refractory Action) study. £749,869.31. MRC 2020-2022.
  • Early detection and treatment of post-partum hemorrhage using the MOTIVE bundle: a World Health Organization cluster randomized trial with health economic analysis (the E-MOTIVE study). $10,915,588 USD. Bill & Melinda Gates Foundation. 2019-2022.
  • A 2x2 factorial design trial of letrozole versus clomiphene and metformin versus placebo for ovulation induction in women with polycystic ovary syndrome (LOCI). £2,100,000. NIHR. 2019-2023
  • Tommy's Reproductive Health Biobank. £1,445,074. MRC. 2017-2021.
  • Tommy’s National Centre for Miscarriage Research. £6,300,000 including institutional investment. Tommy’s. 2016-2021.
  • A randomised trial of mifepristone and misoprostol versus misoprostol alone for management of missed miscarriage (MifeMiso). £1,769,322. NIHR HTA. 2016-2020.
  • Progesterone in Spontaneous Miscarriage (PRISM). £1,756,618. NIHR HTA. 2014-2018.

Research groups and centres

Publications

Recent publications

Article

Muriithi, FG, Easter, C, Osoti, A, Qureshi, Z, Devall, A & Coomarasamy, A 2025, 'An exploration of sub-national variability in institutional maternal mortality ratios in Kenya: a meta-analysis of the 2021 health facility data', Frontiers in Global Women’s Health, vol. 6, 1481495. https://doi.org/10.3389/fgwh.2025.1481495

Bohren, MA, Miller, S, Mammoliti, K-M, Galadanci, H, Fawcus, S, Moran, N, Hofmeyr, GJ, Qureshi, Z, Alwy Al-Beity, F, Forbes, G, Akter, S, Osoti, A, Gwako, G, Melo Santos, T, Evans, C, Wakili, AA, Bakari, M, Takai, IU, Umar, M, Singata-Madliki, M, Muller, E, Mandondo, S, Okore, J, Banda, A, Sambusa, M, Sindhu, KN, Beeson, L, Easter, CL, Devall, A, Gülmezoglu, AM, Althabe, F, Oladapo, OT, Gallos, I, Coomarasamy, A & Lorencatto, F 2025, 'Early detection and a treatment bundle strategy for postpartum haemorrhage: a mixed-methods process evaluation', Lancet Global Health, vol. 13, no. 2, pp. e329-e344. https://doi.org/10.1016/S2214-109X(24)00454-6

Devall, AJ, Nausheen, S, Muhammad, S, Soofi, S, Karmaliani, R, Lakhani, A, Sajid, K, Ahmed, I, Raza, A, Ashraf, A, Shahid, N, Mubeen, K, Wahab, S, Liaquat, R, Evans, C, Martin, JT, Middleton, LJ, Beeson, LE, Sindhu, KN, Podesek, M, Horne, I, Aswat, A, Oladapo, OT, Gallos, ID, Hemming, K, Yunas, I, Sheikh, L & Coomarasamy, A 2025, 'Early Detection and Bundled Treatment of Postpartum Haemorrhage with the E-MOTIVE intervention: A Prospective Pre-Post Intervention Study in Pakistan', The Lancet Obstetrics, Gynaecology and Women's Health. https://doi.org/10.1016/j.lanogw.2025.100010

Koki, C, Shields, R, Sweetman, R, Boyle, J, Khan, O, Lim Choi Keung, SN, Arvanitis, TN, Devall, AJ, Burroughs, NJ & Quenby, S 2025, 'Fertility, time to pregnancy, and pregnancy outcomes among women with recurrent miscarriages in the UK: a prospective observational longitudinal study', The Lancet Regional Health - Europe, vol. 55, 101343. https://doi.org/10.1016/j.lanepe.2025.101343

Leeson, C, Chung, Y, Odendaal, J, Easter, C, Devall, A & Quenby, S 2025, 'Pregnancy outcomes in a recurrent miscarriage population after common uterine surgeries: A multicentre cohort study', Fertility and Sterility. https://doi.org/10.1016/j.fertnstert.2025.10.036

Gallos, I, Williams, CR, Price, MJ, Tobias, A, Devall, A, Allotey, J, Althabe, F, Cresswell, JA, Durocher, J, Gulmezoglu, AM, Haslinger, C, Pacagnella, RC, Sentilhes, L, Sobhy, S, Yunas, I, Deeks, JJ, Coomarasamy, A, Oladapo, OT & WHO Consortium on Postpartum Haemorrhage Definition 2025, 'Prognostic accuracy of clinical markers of postpartum bleeding in predicting maternal mortality or severe morbidity: a WHO individual participant data meta-analysis', The Lancet. https://doi.org/10.1016/S0140-6736(25)01639-3

Fox, CE, Kaur, R, Vigneswaran, K, Small, R, Carter, J, O'Donoghue, K, Heazell, AEP, David, AL, Simpson, N, Care, A, Starrs, L, Shennan, A, González, CMV, Soma‐Pillay, P, Fitzsimmons, L, Devall, AJ, Coomarasamy, A & Mid‐trimester Pregnancy Loss Guideline Consensus Panel 2025, 'Triage and care for women with symptoms or diagnosis of pregnancy loss between 14 + 0 and 21 + 6 weeks' gestation', International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.70621

Muriithi, FG, Ameh, CA, Gakuo, RW, Williams, CR, Devall, A, Coomarasamy, A & Fawcus, S 2025, 'Variability in the Causes and Delay Factors Contributing to Maternal Mortality: Evidence From Maternal Death Surveillance Reports of 22 African Countries', BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/1471-0528.18342

Mammoliti, K-M, Martin, J, Devall, A, Easter, C, Althabe, F, Funmi, AL, Yusuf, R, Abubakar, F, Arigbede, L, Mugambi, J, Oyoo, P, Sambusa, M, Banda, A, Samuels, F, Willemse, S, Khambule, S, Shu’aib, H, Wakili, A, Okore, J, Mwampashi, A, Singata-Madliki, M, Arends, E, Muller, E, Galadanci, H, Qureshi, Z, Alwy Al-Beity, F, Hofmeyr, GJ, Fawcus, S, Moran, N, Osoti, A, Gwako, G, Gallos, I & Coomarasamy, A 2025, 'When are postpartum haemorrhages diagnosed: a nested observational study within the E-MOTIVE cluster-randomised trial', Lancet Global Health.

Mammoliti, K-M, Althabe, F, Easter, C, Devall, A, Martin, J, Funmi, AL, Yusuf, R, Abubakar, F, Arigbede, LC, Mugambi, J, Oyoo, P, Sambusa, M, Banda, A, Samuels, F, Willemse, S, Khambule, SD, Shu'aib, HM, Wakili, AA, Okore, J, Mwampashi, A, Singata-Madliki, M, Arends, E, Muller, E, Galadanci, H, Qureshi, Z, Alwy Al-Beity, F, Hofmeyr, GJ, Fawcus, S, Moran, N, Gwako, G, Osoti, A, Gallos, I & Coomarasamy, A 2025, 'When Is Postpartum Haemorrhage Treatment Initiated? A Nested Observational Study Within the E‐MOTIVE Trial', BJOG: An International Journal of Obstetrics & Gynaecology, vol. 1132, no. 11, pp. 1664-1672. https://doi.org/10.1111/1471-0528.18293

Williams, EV, Goranitis, I, Oppong, R, Perry, SJ, Devall, AJ, Martin, JT, Mammoliti, K-M, Beeson, LE, Sindhu, KN, Galadanci, H, Al-beity, FA, Qureshi, Z, Hofmeyr, GJ, Moran, N, Fawcus, S, Mandondo, S, Middleton, L, Hemming, K, Oladapo, OT, Gallos, ID, Coomarasamy, A & Roberts, TE 2024, 'A cost-effectiveness analysis of early detection and bundled treatment of postpartum haemorrhage alongside the E-MOTIVE trial', Nature Medicine. https://doi.org/10.1038/s41591-024-03069-5

Review article

Yunas, I, Islam, MA, Sindhu, KN, Devall, AJ, Podesek, M, Alam, SS, Kundu, S, Mammoliti, K-M, Aswat, A, Price, MJ, Zamora, J, Oladapo, OT, Gallos, I & Coomarasamy, A 2025, 'Causes of and risk factors for postpartum haemorrhage: a systematic review and meta-analysis', The Lancet, vol. 405, no. 10488, pp. 1468-1480. https://doi.org/10.1016/S0140-6736(25)00448-9

Cheshire, J, Garg, A, Smith, P, Devall, AJ, Coomarasamy, A & Dhillon-Smith, RK 2025, 'Preconception and first trimester metformin on pregnancy outcomes in women with polycystic ovary syndrome: a systematic review and meta-analysis', American journal of obstetrics and gynecology. https://doi.org/10.1016/j.ajog.2025.05.038

Yunas, I, Gallos, ID, Devall, AJ, Podesek, M, Allotey, J, Takwoingi, Y & Coomarasamy, A 2025, 'Tests for diagnosis of postpartum haemorrhage at vaginal birth', Cochrane Database of Systematic Reviews, vol. 2025, no. 1, CD016134. https://doi.org/10.1002/14651858.CD016134

Gallos, I, Yunas, I, Devall, AJ, Podesek, M, Tobias, A, Price, MJ, Oladapo, OT & Coomarasamy, A 2025, 'Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis', Cochrane Database of Systematic Reviews, vol. 2025, no. 4, CD011689. https://doi.org/10.1002/14651858.CD011689.pub4

View all publications in research portal